Literature DB >> 9201757

Cavum septum pellucidum in schizophrenia: a magnetic resonance imaging study.

T Fukuzako1, H Fukuzako, S Kodama, T Hashiguchi, M Takigawa.   

Abstract

In order to determine if cavum septum pellucidum (CSP) is more prevalent in schizophrenic patients, we studied 72 Japanese patients who fulfilled the DSM-III-R criteria for schizophrenia and 41 normal controls. Sagittal, 1 mm thick magnetic resonance imaging slices of the entire cranium were obtained using a gradient-echo pulse sequence, and coronal and axial images were reconstructed for assessment. A CSP was observed in 34 patients (47.2%) and in 16 controls (38.0%). Although the CSP appeared to be more prevalent in schizophrenic patients, this difference was not statistically significant. However, schizophrenic patients with a history of long-term institutionalization had a higher incidence of CSP compared with patients who had not been admitted to hospital for more than 3 years (68.2 vs 38.0%). These results suggest that the CSP may be a pathophysiology that characterizes schizophrenic patients with poor prognoses.

Entities:  

Mesh:

Year:  1996        PMID: 9201757     DOI: 10.1111/j.1440-1819.1996.tb01675.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  10 in total

Review 1.  MRI anatomy of schizophrenia.

Authors:  R W McCarley; C G Wible; M Frumin; Y Hirayasu; J J Levitt; I A Fischer; M E Shenton
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

2.  Cavum septum pellucidum in monozygotic twins discordant for combat exposure: relationship to posttraumatic stress disorder.

Authors:  Flavia S May; Q Cece Chen; Mark W Gilbertson; Martha E Shenton; Roger K Pitman
Journal:  Biol Psychiatry       Date:  2004-03-15       Impact factor: 13.382

3.  Volumetric analysis of septal region in schizophrenia and affective disorder.

Authors:  Ralf Brisch; Hans-Gert Bernstein; Dieter Krell; Renate Stauch; Kurt Trübner; Henrik Dobrowolny; Siegfried Kropf; Hendrik Bielau; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-16       Impact factor: 5.270

4.  Cavum septum pellucidum in schizophrenia: clinical and neuropsychological correlates.

Authors:  Laura A Flashman; Robert M Roth; Heather S Pixley; Howard B Cleavinger; Thomas W McAllister; Robert Vidaver; Andrew J Saykin
Journal:  Psychiatry Res       Date:  2007-02-07       Impact factor: 3.222

Review 5.  A review of MRI findings in schizophrenia.

Authors:  M E Shenton; C C Dickey; M Frumin; R W McCarley
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

6.  Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study.

Authors:  Kiyoto Kasai; Robert W McCarley; Dean F Salisbury; Toshiaki Onitsuka; Susan Demeo; Deborah Yurgelun-Todd; Ron Kikinis; Ferenc A Jolesz; Martha E Shenton
Journal:  Schizophr Res       Date:  2004-11-01       Impact factor: 4.939

7.  Neuroanatomical Risk Factors for Posttraumatic Stress Disorder in Recent Trauma Survivors.

Authors:  Ziv Ben-Zion; Moran Artzi; Dana Niry; Nimrod Jackob Keynan; Yoav Zeevi; Roee Admon; Haggai Sharon; Pinchas Halpern; Israel Liberzon; Arieh Y Shalev; Talma Hendler
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-11-20

8.  Caval variations in neurologically diseased patients.

Authors:  Rachael A Akinola; Olufemi E Idowu; Adedolapo O Nelson-Paseda
Journal:  Acta Radiol Short Rep       Date:  2014-06-13

9.  Prevalence and Characteristics of Cavum Septum Pellucidum in Schizophrenia: A 16 Slice Computed Tomography Study.

Authors:  Sourav Khanra; Naveen Kumar Srivastava; Vivek Chail; Christoday Raja Jayant Khess
Journal:  Indian J Psychol Med       Date:  2016 Sep-Oct

10.  Cavum septum pellucidum and first-episode psychosis: A meta-analysis.

Authors:  Hanwen Liu; Ling Li; Li Shen; Xianliang Wang; Yazhu Hou; Zhiqiang Zhao; Lili Gu; Jingyuan Mao
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.